SEATTLE, Nov. 24 /PRNewswire-FirstCall/ -- Dendreon Corporation today announced that management will present at the Lazard Capital Markets Third Annual Life Sciences Conference at The New York Palace Hotel on Tuesday, November 28 at 10:00 a.m. Eastern Time. The presentation will be audio webcast live and available for replay from Dendreon’s website, www.dendreon.com. The replay of the presentation will be available for 90 days.
About Dendreon
Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate a cell-mediated immune response. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. The Company has headquarters in Seattle and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.
Dendreon Corporation
CONTACT: Monique M. Greer Sr. Director, Corporate Communications ofDendreon Corporation, +1-206-829-1500
Web site: http://www.dendreon.com//
